McAdam LLC
GSK icon

McAdam LLC’s GSK GSK Stock Holding History

McAdam LLC’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$311K Buy
+6,456
New +$330K 0.01% 378
2018
Q4 		– Sell
-225
Closed -$11K – 267
2018
Q3 		$11K Buy
225
+2
+0.9% +$102 ﹤0.01% 325
2018
Q2 		$11K Sell
223
-98
-31% -$4.94K ﹤0.01% 318
2018
Q1 		$16K Buy
+321
New +$14.9K 0.01% 275

Other funds holding GSK

Mondrian Investment Partners
Mondrian Investment Partners London, United Kingdom $5.39B AUM 14.53% 1-Year Est. Return
Miller Howard Investments
Miller Howard Investments Kingston, New York $3.72B AUM 18.2% 1-Year Est. Return
BI Asset Management Fondsmaeglerselskab
BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return
Douglas Lane & Associates
Douglas Lane & Associates New York $7.46B AUM 24.36% 1-Year Est. Return
AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
ABC Arbitrage
ABC Arbitrage Paris, France $1.02B AUM 30.46% 1-Year Est. Return
Foster Victor Wealth Advisors
Foster Victor Wealth Advisors Greenville, South Carolina $2.02B AUM 20.94% 1-Year Est. Return
Sound Income Strategies
Sound Income Strategies Ft Lauderdale, Florida $2.24B AUM 8.38% 1-Year Est. Return
Euro Pacific Asset Management
Euro Pacific Asset Management Dorado, Puerto Rico $1.22B AUM 22.48% 1-Year Est. Return
Keystone Financial Planning
Keystone Financial Planning Cleveland, Ohio $404M AUM 16.77% 1-Year Est. Return

McAdam LLC's GSK Position: Q3 2026 in Review

McAdam LLC opened a new position in GSK (GSK) in Q3 2026: 6,456 shares worth $311K. The stake represents 0.01% of the portfolio and ranks #378 among its holdings. This is a return to the name: McAdam LLC previously reported a position in GSK as recently as Q3 2018.

McAdam LLC first reported a position in GSK in Q1 2018 and has held it in 4 quarters since. 314 funds tracked by Wall St. Rank hold GSK as of Q3 2026.

  • McAdam LLC held 6,456 shares of GSK worth $311K as of Q3 2026.
  • GSK was a new McAdam LLC position in Q3 2026.
  • GSK made up 0.01% of McAdam LLC's portfolio in Q3 2026, its #378 holding.
  • McAdam LLC first reported a position in GSK in Q1 2018 and has held it in 4 quarters since.
  • 314 funds tracked by Wall St. Rank held GSK as of Q3 2026.

Based on McAdam LLC's 13F filing for Q3 2026, filed 21 Oct 2026.